Stocks › CSTL
CASTLE BIOSCIENCES INC
CSTL·Nasdaq·
United States·USD
$32.86
-0.55 (-1.63%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
CSTL
CASTLE BIOSCIENCES INC · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CSTLS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CSTL by members of U.S. Congress · 3 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Josh GottheimerHouse · D · NJ |
CSTLCASTLE BIOSCIENCES INC · Stock |
Sale $1,001 - $15,000 |
Apr 17, 2022 | Mar 15, 2022 | Filing ↗ |
Gilbert Ray Cisneros, Jr.House · D · CA |
CSTLCASTLE BIOSCIENCES INC · Stock |
Purchase $1,001 - $15,000 |
Jan 11, 2021 | Dec 23, 2020 | Filing ↗ |
Josh GottheimerHouse · D · NJ |
CSTLCASTLE BIOSCIENCES INC · Stock |
Purchase $1,001 - $15,000 |
Jan 7, 2021 | Dec 21, 2020 | Filing ↗ |
Whale Activity
Position changes in CSTL reported for 2026-09-30 by 225 institutional filers
- Increased72
- New49
- Held18
- Decreased54
- Closed22
- No prior filing10
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 3.5M | $122.7M | increased |
| RTW INVESTMENTS, LP | 2.8M | $98.7M | held |
| PRINCIPAL FINANCIAL GROUP INC | 1.5M | $53.3M | — |
| Portolan Capital Management, LLC | 1.4M | $48.8M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $44.0M | increased |
| ACADIAN ASSET MANAGEMENT LLC | 881.9K | $31.3M | decreased |
| STATE STREET CORP | 804.7K | $28.6M | decreased |
| GEODE CAPITAL MANAGEMENT, LLC | 793.9K | $28.2M | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 716.7K | $25.5M | decreased |
| DIMENSIONAL FUND ADVISORS LP | 692.1K | $24.6M | decreased |
| Jefferies Financial Group Inc. | 647.4K | $23.0M | held |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 635.0K | $22.6M | decreased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CSTL insiders, by quarter · Form 4
Recent Insider Transactions
2,778 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| MAETZOLD DEREK JPres. & Chief Exec. Officer · Director | Sale | −3,904 | $32.92 | $129K | Nov 16, 2026 | Form 4 ↗ |
| MAETZOLD DEREK JPres. & Chief Exec. Officer · Director | Sale | −1,642 | $32.92 | $54K | Nov 16, 2026 | Form 4 ↗ |
| MAETZOLD DEREK JPres. & Chief Exec. Officer · Director | Sale | −1,396 | $32.92 | $46K | Nov 16, 2026 | Form 4 ↗ |
| Juvenal Tobin WChief Commercial Officer | Sale | −3,195 | $35.07 | $112K | Nov 11, 2026 | Form 4 ↗ |
| Juvenal Tobin WChief Commercial Officer | Sale | −2,828 | $35.04 | $99K | Nov 11, 2026 | Form 4 ↗ |
| Juvenal Tobin WChief Commercial Officer | Sale | −3,288 | $32.67 | $107K | Nov 9, 2026 | Form 4 ↗ |
| MAETZOLD DEREK JPres. & Chief Exec. Officer · Director | Sale | −7,555 | $36.01 | $272K | Nov 2, 2026 | Form 4 ↗ |
| MAETZOLD DEREK JPres. & Chief Exec. Officer · Director | Sale | −382 | $36.81 | $14K | Nov 2, 2026 | Form 4 ↗ |
| MAETZOLD DEREK JPres. & Chief Exec. Officer · Director | Sale | −325 | $36.81 | $12K | Nov 2, 2026 | Form 4 ↗ |
| MAETZOLD DEREK JPres. & Chief Exec. Officer · Director | Sale | −2,816 | $36.01 | $101K | Nov 2, 2026 | Form 4 ↗ |
| MAETZOLD DEREK JPres. & Chief Exec. Officer · Director | Sale | −2,393 | $36.01 | $86K | Nov 2, 2026 | Form 4 ↗ |
| MAETZOLD DEREK JPres. & Chief Exec. Officer · Director | Sale | −1,025 | $36.81 | $38K | Nov 2, 2026 | Form 4 ↗ |
| Juvenal Tobin WChief Commercial Officer | Sale | −5,341 | $36.62 | $196K | Oct 28, 2026 | Form 4 ↗ |
| Juvenal Tobin WChief Commercial Officer | Sale | −1,237 | $35.58 | $44K | Oct 28, 2026 | Form 4 ↗ |
| Juvenal Tobin WChief Commercial Officer | Sale | −3,288 | $33.08 | $109K | Oct 26, 2026 | Form 4 ↗ |
| MAETZOLD DEREK JPres. & Chief Exec. Officer · Director | Sale | −8,580 | $31.91 | $274K | Oct 19, 2026 | Form 4 ↗ |
| MAETZOLD DEREK JPres. & Chief Exec. Officer · Director | Sale | −3,198 | $31.91 | $102K | Oct 19, 2026 | Form 4 ↗ |
| MAETZOLD DEREK JPres. & Chief Exec. Officer · Director | Sale | −2,718 | $31.91 | $87K | Oct 19, 2026 | Form 4 ↗ |
| Juvenal Tobin WChief Commercial Officer | Sale | −3,288 | $33.64 | $111K | Oct 12, 2026 | Form 4 ↗ |
| MAETZOLD DEREK JPres. & Chief Exec. Officer · Director | Sale | −8,580 | $35.57 | $305K | Oct 5, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CSTL · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 793.4K | $26.2M | 0.03% | Aug 31, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 852.7K | $20.3M | 0.00% | Jun 30, 2026 |
| SmallCap Fund Principal Funds, Inc | 725.1K | $20.3M | 0.97% | Jul 31, 2026 |
| iShares Russell 2000 ETF iShares Trust | 781.4K | $18.6M | 0.02% | Jun 30, 2026 |
| Wasatch Micro Cap Fund WASATCH FUNDS TRUST | 276.7K | $9.8M | 1.73% | Sep 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 327.8K | $9.2M | 0.03% | Jul 31, 2026 |
| Buffalo Small Cap Growth Fund Buffalo Funds | 239.6K | $8.5M | 2.07% | Sep 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 342.7K | $8.2M | 0.01% | Jun 30, 2026 |
| VANGUARD EXPLORER FUND | 275.9K | $7.7M | 0.03% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF iShares Trust | 278.7K | $6.6M | 0.05% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list CSTL's shares (CUSIP 14843C105), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- PRINCIPAL GLOBAL INVESTORSSCHEDULE 13G/A · passive (13G) · 1.5M shares4.9%
Oct 29, 2026 · ↗ - Roderick WongSCHEDULE 13G/A · passive (13G) · 2.8M shares9.3%
May 15, 2026 · ↗ - RTW Investments, LPSCHEDULE 13G/A · passive (13G) · 2.8M shares9.3%
May 15, 2026 · ↗ - George McCabeSCHEDULE 13G/A · passive (13G) · 1.4M shares4.5%
May 15, 2026 · ↗ - Portolan Capital Management, LLCSCHEDULE 13G/A · passive (13G) · 1.4M shares4.5%
May 15, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming castle biosciences as client
- MCDERMOTT+ LLCCASTLE BIOSCIENCES, INC. · 2026 Q3 · MMM$25K
Filing ↗ - MCDERMOTT+ LLCCASTLE BIOSCIENCES, INC. · 2026 Q2 · MMM$40K
Filing ↗ - MCDERMOTT+ LLCCASTLE BIOSCIENCES, INC. · 2026 Q1 · MMM$40K
Filing ↗ - MCDERMOTT+ LLCCASTLE BIOSCIENCES, INC. · 2025 Q4 · MMM$40K
Filing ↗ - MCDERMOTT+ LLCCASTLE BIOSCIENCES, INC. · 2025 Q3 · MMM$40K
Filing ↗
Government Contracts
Federal awards to castle biosciences · USAspending
$167KAwarded · 2 contracts on record
U.S. Patents
Recent USPTO applications naming CASTLE BIOSCIENCES INC
No USPTO patent applications found for CASTLE BIOSCIENCES INC.
Annual Financials
From CSTL's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $344.2M | $332.1M | $219.8M | $137.0M | $94.1M |
| Operating income | -$42.8M | $8.7M | -$68.0M | -$72.9M | -$40.1M |
| Net income | -$24.2M | $18.2M | -$57.5M | -$67.1M | -$31.3M |
| Diluted EPS | -$0.83 | $0.62 | -$2.14 | -$2.58 | -$1.24 |
| Operating cash flow | $64.3M | $64.9M | -$5.6M | -$41.7M | -$19.0M |
| Cash and equivalents | $116.7M | $119.7M | $98.8M | $122.9M | $329.6M |
| Total assets | $578.6M | $531.2M | $453.3M | $447.3M | $462.6M |
| Total liabilities | $107.7M | $75.4M | $62.1M | $48.2M | $50.8M |
| Shareholders' equity | $470.9M | $455.8M | $391.3M | $399.1M | $411.7M |
As CASTLE BIOSCIENCES INC tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 26, 2026 ↗
Stock Splits
Every split and reverse split in the price history
No stock splits in CSTL's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureNov 5, 2026
EDGAR ↗ - 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureJul 30, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteMay 29, 2026
EDGAR ↗ - 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureMay 6, 2026
EDGAR ↗
About CASTLE BIOSCIENCES INC
From SEC EDGAR company records
Industry (SIC 8071)Services-Medical Laboratories
SectorHealthcare
HeadquartersFRIENDSWOOD, TX
IncorporatedDE
SEC CIK0001447362 ↗


